Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway

Wang, F; Liu, C; Ren, LZ; Li, YY; Yang, HM; Yu, Y; Xu, WP

Yu, Y (通讯作者)，Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Peoples R China.;Xu, WP (通讯作者)，Guangdong Prov Peoples Hosp, Nucl Med Dept, Guangzhou, Peoples R China.;Xu, WP (通讯作者)，Guangdong Prov Peoples Hosp, Nucl Med Dept, Guangzhou 510080, Guangdong, Peoples R China.;Yu, Y (通讯作者)，Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.

PHARMACEUTICAL BIOLOGY, 2023; 61 (1): 427

Abstract

Context Sanziguben (SZGB) is an empirical prescription used in traditional Chinese medicine to treat diabetic nephropathy (DN). As an abundant and pri......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索